Cancer Research AACR Membership Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, H.-M.
Right arrow Articles by Fox, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, H.-M.
Right arrow Articles by Fox, B. A.
[Cancer Research 62, 3914-3919, July 15, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

Development of Antitumor Immune Responses in Reconstituted Lymphopenic Hosts1

Hong-Ming Hu2, Christian H. Poehlein, Walter J. Urba and Bernard A. Fox

Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center [H-M. H., C. H. P., W. J. U., B. A. F.], Portland, Oregon 97213, and Departments of Biochemistry and Molecular Biology [H-M. H., B. A. F.] and Molecular Microbiology and Immunology [B. A. F.], Oregon Health and Science University, Portland, Oregon 97201

When naïve T cells reconstitute lymphopenic hosts, they transiently proliferate and differentiate into memory-like T cells. Here we report that tumor-specific T cells preferentially expand in tumor vaccine-draining lymph nodes after a melanoma vaccine given to RAG1 mice reconstituted with naïve T cells from normal mice. The percentage of tumor-specific Tc1 T cells detected by intracellular cytokine staining was increased ~4-fold in reconstituted lymphopenic hosts compared with normal hosts. Concomitantly, vaccination-induced Th1 T cells were also dramatically increased in vaccinated, reconstituted RAG1 hosts. T cells derived from reconstituted RAG1 hosts exhibited a higher level of melanoma-specific cytotoxicity in vitro. These cells were significantly more potent at mediating tumor regression in vivo after adoptive transfer into mice bearing established pulmonary metastases. Vaccination is best performed concomitantly with reconstitution; delayed vaccination resulted in T cells with less therapeutic activity.




This article has been cited by other articles:


Home page
 BloodHome page
W. Jing, J. A. Gershan, and B. D. Johnson
Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory
Blood, April 30, 2009; 113(18): 4449 - 4457.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Shvets, R. Chakrabarti, R. Gonzalez-Quintial, R. Baccala, A. N. Theofilopoulos, and G. J. Prud'homme
Impaired negative regulation of homeostatically proliferating T cells
Blood, January 15, 2009; 113(3): 622 - 625.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. J. Pegram, J. T. Jackson, M. J. Smyth, M. H. Kershaw, and P. K. Darcy
Adoptive Transfer of Gene-Modified Primary NK Cells Can Specifically Inhibit Tumor Progression In Vivo
J. Immunol., September 1, 2008; 181(5): 3449 - 3455.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S.-J. Lin, A. T. Chen, and R. M. Welsh
Immune system derived from homeostatic proliferation generates normal CD8 T-cell memory but altered repertoires and diminished heterologous immune responses
Blood, August 1, 2008; 112(3): 680 - 689.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Voehringer, H.-E. Liang, and R. M. Locksley
Homeostasis and Effector Function of Lymphopenia-Induced "Memory-Like" T Cells in Constitutively T Cell-Depleted Mice
J. Immunol., April 1, 2008; 180(7): 4742 - 4753.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Kobayashi, H. Hara, M. Ohashi, T. Nishimoto, K. Yoshida, N. Ohkohchi, T. Yoshida, and K. Aoki
Allogeneic MHC Gene Transfer Enhances an Effective Antitumor Immunity in the Early Period of Autologous Hematopoietic Stem Cell Transplantation
Clin. Cancer Res., December 15, 2007; 13(24): 7469 - 7479.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L.-X. Wang, R. Li, G. Yang, M. Lim, A. O'Hara, Y. Chu, B. A. Fox, N. P. Restifo, W. J. Urba, and H.-M. Hu
Interleukin-7-Dependent Expansion and Persistence of Melanoma-Specific T Cells in Lymphodepleted Mice Lead to Tumor Regression and Editing
Cancer Res., November 15, 2005; 65(22): 10569 - 10577.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
H. Zhang and G. G. Meadows
Chronic alcohol consumption in mice increases the proportion of peripheral memory T cells by homeostatic proliferation
J. Leukoc. Biol., November 1, 2005; 78(5): 1070 - 1080.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L.-X. Wang, S. Shu, and G. E. Plautz
Host Lymphodepletion Augments T Cell Adoptive Immunotherapy through Enhanced Intratumoral Proliferation of Effector Cells
Cancer Res., October 15, 2005; 65(20): 9547 - 9554.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. A. Emens and E. M. Jaffee
Leveraging the Activity of Tumor Vaccines with Cytotoxic Chemotherapy
Cancer Res., September 15, 2005; 65(18): 8059 - 8064.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Baccala, D. Witherden, R. Gonzalez-Quintial, W. Dummer, C. D. Surh, W. L. Havran, and A. N. Theofilopoulos
{gamma}{delta} T Cell Homeostasis Is Controlled by IL-7 and IL-15 Together with Subset-Specific Factors
J. Immunol., April 15, 2005; 174(8): 4606 - 4612.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
L A Emens, R T Reilly, and E M Jaffee
Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity
Endocr. Relat. Cancer, March 1, 2005; 12(1): 1 - 17.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. A. Mihalyo, A. D. H. Doody, J. P. McAleer, E. C. Nowak, M. Long, Y. Yang, and A. J. Adler
In Vivo Cyclophosphamide and IL-2 Treatment Impedes Self-Antigen-Induced Effector CD4 Cell Tolerization: Implications for Adoptive Immunotherapy
J. Immunol., May 1, 2004; 172(9): 5338 - 5345.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L.-X. Wang, J. Kjaergaard, P. A. Cohen, S. Shu, and G. E. Plautz
Memory T Cells Originate from Adoptively Transferred Effectors and Reconstituting Host Cells after Sequential Lymphodepletion and Adoptive Immunotherapy
J. Immunol., March 15, 2004; 172(6): 3462 - 3468.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. D. Peacock, S.-K. Kim, and R. M. Welsh
Attrition of Virus-Specific Memory CD8+ T Cells During Reconstitution of Lymphopenic Environments
J. Immunol., July 15, 2003; 171(2): 655 - 663.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. Prlic, B. R. Blazar, M. A. Farrar, and S. C. Jameson
In Vivo Survival and Homeostatic Proliferation of Natural Killer Cells
J. Exp. Med., April 21, 2003; 197(8): 967 - 976.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.